BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the design and development of ...

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in ...

The hereditary transthyretin amyloidosis market is experiencing significant growth driven by increasing disease awareness, ...